Charité – Universitätsmedizin Berlin Launches Central Study Register

On May 12, Charité – Universitätsmedizin Berlin launched its central study register, which was developed using the CentraXX Study Register module.

Dr. Patrick Schmerler, Head of the QA Unit Clinical Trials:

“With the registration of all clinical studies within a central study register, we will have a comprehensive and up-to-date overview of the clinical studies undertaken at the Charité. The Central Study Registry (ZSR) of the Charité also gives each study manager the opportunity to maintain the master data of the respective study within the CentraXX Study Registry module and thus obtain an audit-proof overview of their own studies. In addition, the register contributes to the quality assurance of clinical research.”

All study managers at the Charité now have access to a rights- and role-based overview of the studies within their area of responsibility. As part of their tasks, the study master data must be kept up-to-date. The content of the CentraXX study registry is based on the German Register for Clinical Studies (DRKS), so that certain data points can be exported from the ZSR of the Charité to the DRKS.

On the ‘Clinical Trials Presentation Platform‘ interested patients/test persons can download current and planned clinical trials of the Charité – taken from the CentraXX Study Register – as well as information on the current and planned clinical trials. This allows patients/test persons to stay informed about studies they are suitable for.

Almost 400 hits on the first day

“Already on the day of commissioning and communicating the Central Study Registry (ZSR) of the Charité, almost 400 employees of the Charité accessed it. We are pleased that we were able to play our part in the success of the project in close cooperation with our contacts at the Charité,” said Franzy Hohnstädter, project manager at KAIROS GmbH.

 

KAIROS GmbH – NOW IS THE TIME.

 

KAIROS GmbH
Contact / Public Relations
Dirk Link
Universitätsstraße 136
44799 Bochum
E-Mail:
Tel: (49) 234 58 88 21 -15